1,200
Participants
Start Date
November 30, 2014
Primary Completion Date
February 28, 2015
Study Completion Date
April 30, 2015
2.5IU/ml rabies vaccine(MRC-5 cell) in humans aged 10-20 years old
freeze-dried rabies vaccine(MRC-5 cell) of 2.5IU/ml, 5 doses, 4 weeks interval
2.5IU/ml rabies vaccine(MRC-5 cell) in humans aged 21-50 years old
freeze-dried rabies vaccine(MRC-5 cell) of 2.5IU/ml, 5 doses, 4 weeks interval
2.5IU/ml rabies vaccine(MRC-5 cell) in humans aged 51-60 years old
freeze-dried rabies vaccine(MRC-5 cell) of 2.5IU/ml, 5 doses, 4 weeks interval
2.5IU/ml rabies vaccine(vero cell) in humans aged 10-20 years old
freeze-dried rabies vaccine(vero cell) of 2.5IU/ml, 5 doses, 4 weeks interval
2.5IU/ml rabies vaccine(vero cell) in humans aged 21-50 years old
freeze-dried rabies vaccine(vero cell) of 2.5IU/ml, 5 doses, 4 weeks interval
2.5IU/ml rabies vaccine(vero cell) in humans aged 51-60 years old
freeze-dried rabies vaccine(vero cell) of 2.5IU/ml, 5 doses, 4 weeks interval
Collaborators (1)
Beijing Minhai Biotechnology Co., Ltd
INDUSTRY
Beijing Center for Disease Control and Prevention
OTHER_GOV